<p>Antigens in the form of peptides or recombinant monomer/oligomer protein preparations as described in the methods were coated on to microtitre plates and ELISA reading measured with fixed concentrations of serum IgG antibodies (at OD50 dilution) purified from pooled sera of vaccinated mice (n = 4), preincubated with serial dilutions of (A) free a-syn peptides (PD1, left; PD3, right); (B) free a-syn protein, either monomeric (left panels) or oligomeric (right panels) species, PD1 (top) and PD3 (bottom); and (C) liberated a-syn from haemolysed RBCs (orange line) or PBS negative control (blue line) for PD1 (top) and PD3 (bottom).</p
(A) Immunization scheme. Balb/c mice were immunized three times on days 0, 21, and 42, and blood was...
The characterisation of monoclonal antibodies (MAbs) is essential for the development of assay syste...
Mice (n = 5) were immunised with a panel of GP encapsulated antigens and the development humoral and...
<p>(A) VNNESSE-variants, (B) FIGITEL-variants, (C) SYFPSV-variants and (D) PNRDIL-variants. Control ...
<p>PBS was used as the negative control. Ability of IgG1 (A) and IgG2a (B) antibodies binds to the H...
<p>(A) Endpoint titers (serum dilution reaching 5 times the background) for TT specific IgG antibodi...
<p>(A) B[a]P-BA, (B) B[a]P, and (C) 7,8-diol-B[a]P were used as competitors to compete for binding o...
<p>[A] Sera collected after first booster (14<sup>th</sup> day) and second boosters (21<sup>st</sup>...
<p>Groups of three to four mice each were vaccinated at days 0, 14, 28 and 126 (downward pointing op...
<p>PBS was used as the negative control. Ability of IgG binding to HA1 (HA-13–263-His) protein (A) a...
<p><b>A</b>. The serum IgG against TP or the individual virus serotypes was measured by indirect ELI...
<p>BALB/c mice were immunized with recombinant proteins as described in the Materials and Methods. O...
Choosing optimum pair of capturing antibody and detecting antibody when developing monoclonal antibo...
Choosing optimum pair of capturing antibody and detecting antibody when developing monoclonal antibo...
Choosing optimum pair of capturing antibody and detecting antibody when developing monoclonal antibo...
(A) Immunization scheme. Balb/c mice were immunized three times on days 0, 21, and 42, and blood was...
The characterisation of monoclonal antibodies (MAbs) is essential for the development of assay syste...
Mice (n = 5) were immunised with a panel of GP encapsulated antigens and the development humoral and...
<p>(A) VNNESSE-variants, (B) FIGITEL-variants, (C) SYFPSV-variants and (D) PNRDIL-variants. Control ...
<p>PBS was used as the negative control. Ability of IgG1 (A) and IgG2a (B) antibodies binds to the H...
<p>(A) Endpoint titers (serum dilution reaching 5 times the background) for TT specific IgG antibodi...
<p>(A) B[a]P-BA, (B) B[a]P, and (C) 7,8-diol-B[a]P were used as competitors to compete for binding o...
<p>[A] Sera collected after first booster (14<sup>th</sup> day) and second boosters (21<sup>st</sup>...
<p>Groups of three to four mice each were vaccinated at days 0, 14, 28 and 126 (downward pointing op...
<p>PBS was used as the negative control. Ability of IgG binding to HA1 (HA-13–263-His) protein (A) a...
<p><b>A</b>. The serum IgG against TP or the individual virus serotypes was measured by indirect ELI...
<p>BALB/c mice were immunized with recombinant proteins as described in the Materials and Methods. O...
Choosing optimum pair of capturing antibody and detecting antibody when developing monoclonal antibo...
Choosing optimum pair of capturing antibody and detecting antibody when developing monoclonal antibo...
Choosing optimum pair of capturing antibody and detecting antibody when developing monoclonal antibo...
(A) Immunization scheme. Balb/c mice were immunized three times on days 0, 21, and 42, and blood was...
The characterisation of monoclonal antibodies (MAbs) is essential for the development of assay syste...
Mice (n = 5) were immunised with a panel of GP encapsulated antigens and the development humoral and...